MUMBAI, India, May 2 -- Intellectual Property India has published a patent application (202517027578 A) filed by Benevolentai Cambridge Limited, London, on March 25, for 'compounds and their use in the treatment of neurodegenerative disorders and cancers.'
Inventor(s) include Almond-Thynne, Joshua; Carter, Michael K; Watts, Ellen; Caine, Bethan; and Lainchbury, Michael.
The application for the patent was published on May 2, under issue no. 18/2025.
According to the abstract released by the Intellectual Property India: "The present invention relates to compounds of Formula (I) that may act as agonists of retinoic acid receptor alpha (RAR-a) and/or retinoic acid receptor beta (RAR-). The invention also relates to pharmaceutical composition...